BioCentury
ARTICLE | Company News

Immune Design, Sanofi deal

August 11, 2014 7:00 AM UTC

Immune Design granted Sanofi exclusive rights to discover, develop and commercialize products to treat an undisclosed food allergy using Immune Design’s GLAAS TLR4 agonism discovery platform. Immune ...